| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $139.7M | +0.0% |
| R&D Expense | $118.5M | +34.3% |
| SG&A Expense | $33.3M | +31.8% |
| Operating Income | -$151.8M | -678.8% |
| Interest Expense | $3.1M | +65.2% |
| Income Tax | $0 | — |
| Net Income | -$149.3M | -699.1% |
| EPS (Basic) | -$2.46 | -612.5% |
| EPS (Diluted) | -$2.46 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $74.4M | -66.5% |
| Short-term Investments | $401.4M | +84.2% |
| Current Assets | $489.8M | +9.2% |
| Total Assets | $497.2M | +10.6% |
| Current Liabilities | $29.1M | +40.5% |
| Total Liabilities | $29.8M | -27.9% |
| Stockholders' Equity | $467.4M | +14.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$133.7M | -558.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | -$186.2M | -355.5% |
| Financing Cash Flow | $172.3M | +45.4% |
| Free Cash Flow | -$133.7M | -560.9% |
| -634.8% |